Who is sponsoring NCT04954976?

NCT04954976 is sponsored by Nantes University Hospital.

What drugs are being tested in NCT04954976?

Interventions in NCT04954976: Orthodontic retention procedures survey.

What condition does NCT04954976 study?

NCT04954976 studies Orthodontic Retention Procedures.

Is NCT04954976 still recruiting?

NCT04954976 is currently completed. Last updated 8 July 2021.

Last reviewed 2021-07-08 · How we verify

NCT04954976: ORIF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Orthodontic Retention In France - ORIF

Completed Last updated 8 July 2021

What this trial tests

trial testing Orthodontic retention procedures survey in Orthodontic Retention Procedures in 262 participants. Completed in 2 February 2021.

Timeline

18 January 2021

Primary endpoint
2 February 2021

2 February 2021

Quick facts

Lead sponsor	Nantes University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	262
Start date	18 January 2021
Primary completion	2 February 2021
Estimated completion	2 February 2021
Sites	1 location across France

Drugs / interventions tested

Orthodontic retention procedures survey

Conditions studied

Orthodontic Retention Procedures — all drugs for Orthodontic Retention Procedures →

Sponsor

Nantes University Hospital

Who can join

18 and older, any sex, with Orthodontic Retention Procedures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to survey retention procedures used by French orthodontists, and evaluate the needs for practice guidelines. The hypothesis is that there is no consensus among orthodontists, requiring practice homogenization via expert guidelines. Similar studies have been driven in others European countries (such as Swiss, the Netherlands, Lithuania and Norway), but not in France.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Nantes University Hospital trials

Trials by the same sponsor.

NCT07278661 — Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. · Phase 2 · recruiting
NCT06681363 — Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelod · not yet recruiting
NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
NCT07490379 — Comparison of the Efficacy of Transcranial Direct Current Stimulation at Home Versus in Hospital Settings in Patients Wi · NA · not yet recruiting
NCT07423481 — Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04954976 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nantes University Hospital
Last refreshed: 8 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04954976.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing